Multiple studies have found an expansion of M‐MDSCs/MDSC‐like cells in patients with severe COVID‐19, characterized by low expression of HLA‐DR and CD86 and increased ROS production and S100A8/A9 [4, 24, 26, 27, 42, 64, 82, 87]. Here, CD86 is linked to COVID-19.